by Andrea Marra | Jul 26, 2023 | Clinical, CRO, Molecular, Pharmaceutical
At any given time, one in five people in the US has a sexually transmitted infection (STI), translating to more than 60 million infections per year.1 These infections cost billions in healthcare expenses each year. Even more alarming, over 40% of all new STIs in this...
by Microbiologics | Jun 26, 2023 | Clinical, Molecular
The CDC and other health organizations recognize July as International Group B Streptococcus (Group B Strep, GBS) month. In many ways, Group B Strep seems somewhat harmless, remaining asymptomatic for most healthy adults who carry the bacteria. Yet the same factors...
by Lindsey Drake | Apr 3, 2023 | Clinical, Molecular
This blog post is the third in our Optimal QC in the Clinical Laboratory series. Previously, in this series we highlighted the importance of external and third-party quality control products in the clinical laboratory, emphasizing that quality control, by design,...
by Lindsey Drake | Apr 3, 2023 | Clinical, Molecular
This blog post is the second in our Optimal QC in the Clinical Laboratory series. In a previous blog post, we highlighted the importance of external quality control products for QC in the clinical laboratory, rather than relying solely on internal controls built into...
by Lindsey Drake | Mar 30, 2023 | Clinical, Molecular
This post on external quality controls is the first in our series on Optimal QC in the Clinical Laboratory, which also covers third-party controls and IVD labelled controls. By principle, quality control (QC) in the clinical laboratory must subject all...
by Andrea Marra | Dec 14, 2022 | Molecular, SARS-CoV-2
Perhaps you have heard that we could be facing a potential “tridemic,” with SARS-CoV-2 (COVID-19), Flu A/B, and a lesser-known third virus–respiratory syncytial virus, or RSV–set to be swirling around us at the same time in the fall/winter of 2022 – 2023. RSV has...
